ArticleGenome medicine2017

Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications.

Shuyu D Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.